Hunter's Quest for the Cure

Hunter's Quest for the Cure Charcot-Marie-Tooth disease (CMT) is an inherited neurological disorder for which there is no treatment or cure. Hunter needs your help to change that.

Charcot-Marie-Tooth disease (CMT) is one of the most common inherited neurological disorders, affecting approximately 1 in 2,500 people in the United States. CMT, also known as hereditary motor and sensory neuropathy (HMSN) or peroneal muscular atrophy, comprises a group of disorders caused by mutations in genes that affect the normal function of the peripheral nerves. The peripheral nerves lie o

utside the brain and spinal cord and supply the muscles and sensory organs in the limbs. A typical feature includes weakness of the foot and lower leg muscles, which may result in foot drop and a high-stepped gait with frequent tripping or falls. Foot deformities, such as high arches and hammertoes (a condition in which the middle joint of a toe bends upwards), are also characteristic due to weakness of the small muscles in the feet. In addition, the lower legs may take on an "inverted champagne bottle" appearance due to the loss of muscle bulk. Later in the disease, weakness and muscle atrophy may occur in the hands, resulting in difficulty with fine motor skills. Some patients experience pain, which can range from mild to severe.

06/19/2026

BREAKING: The Justice Department just moved to gut the legal foundation of disabled people's right to live in their own homes. Today, June 18, the DOJ's Office of Legal Counsel issued a formal opinion concluding that the "integration mandate" was never actually required by the ADA or the Rehabilitat...

06/16/2026
06/16/2026

💙 Need help accessing mobility or daily living equipment?

If you’re living with Charcot-Marie-Tooth disease (CMT), the Muscular Dystrophy Association (MDA) offers a Durable Medical Equipment (DME) Grant Program that may be able to help.
Apply here: https://www.mda.org/care/resource-list/equipment-assistance
✨ This program provides assistance for essential equipment that supports greater independence, safety, and mobility at home, school, work, and in the community.

Equipment may include:
🦽 Mobility aids
🪑 Lift chairs
🏠 Other durable medical equipment that can improve quality of life

✅ Who is eligible?
You or your loved one must:
• Have a physician-confirmed diagnosis of a neuromuscular disease covered by MDA
• Be a U.S. citizen or legal permanent resident
• Be a registered MDA member (membership is FREE and automatic when you apply)

📝 How to apply:
Applications are accepted year-round through MDA’s online grant platform. After creating an account, you’ll complete the DME Grant application. An assigned MDA Specialist will review your application and guide you through the process every step of the way.

💙 Access to the right equipment can make a meaningful difference in everyday life. If you or a loved one could benefit from additional support, we encourage you to explore this valuable resource.

06/12/2026

If summer had a highlight reel, camp would make the cut. ☀️🎬

💙💛 MDA Summer Camp is a place for kids living with neuromuscular disease to connect, have fun, and create memories and friendships that last a lifetime.

👉 Apply today: https://www.mda.org/summer-camp

06/07/2026

On June 1, 2026, the Centers for Medicare and Medicaid Services (CMS) issued the Interim Final Rule (IFR): Medicaid Program; Community Engagement Requirement for Certain Individuals to establish federal guidelines for states as they implement these requirements. Read it here: https://www.cms.gov/newsroom/fact-sheets/medicaid-community-engagement-requirement-certain-individuals-interim-final-rule-comment-period-cms

While the EveryLife Foundation team is still reading through the rule to understand its impact on the rare disease community, we would like to highlight several themes that will be particularly important to our community as states implement new guidance:

➡️ First, there are several definitions in the rule around disability, medical complexity, and medical frailty, and their connection to the ability to work. We are exploring the effect of these definitions on the eligibility of our rare community.

➡️ Second, the rule includes guidelines for how and when individuals receiving Medicaid can self-attest (or sign off) that they meet the exclusion requirements without further documentation.

➡️ Third, the rule outlines how states can decide whether someone qualifies as disabled or medically complex, encouraging the use of healthcare code lists that do not account for significant numbers of rare diseases.

➡️Fourth, the rule describes caregiving exemptions for parents of young children and those caring for people with disabilities. We are working to better understand how our rare disease community can qualify for these important exemptions from work requirements.

Please visit our website to read our full breakdown of the rule: https://everylifefoundation.org/what-our-community-should-know-about-cms-medicaid-work-requirement-rule/

We know that Medicaid is a lifeline for our rare disease community that enables our community members to live and thrive, and we will continue to keep the community updated as more information is made available.

06/07/2026

Some students with disabilities rely on assistive technology to learn, and they worry it could be swept up in the movement to get screens out of schools.

06/06/2026

Disability inclusion is not separate from customer experience. It determines who can participate, how easily they can engage, and whether they are able to return for repeat business. Organizations that invest in accessibility and inclusion are better positioned to serve more customers, reduce lost opportunities, and build stronger, more durable relationships. Those that do not risk creating barriers that limit both access and growth.

Learn more about the impact of disability inclusion on customers and consumers in the fourth blog in our Business Case for Inclusion series: www.DisabilityBelongs.org/2026/06/business-case-inclusion-customers-consumers/

Read the full series at www.DisabilityBelongs.org/Business-Case

06/05/2026

Today, NORD CEO Pamela Gavin issued a statement expressing concerns regarding the newly released CMS Community Engagement Requirements and potential unintended challenges for people with rare diseases and the caregivers who support them across the 40 states and D.C. where the requirements are expected to apply.

Healthcare policies are most effective when they work for the most medically complex populations, including those living with a rare disease.

Read the full statement from NORD’s CEO here: https://rarediseases.org/nord-ceo-statement-in-response-to-cms-medicaid-community-engagement-requirements/

NORD will continue to work closely with state Medicaid leaders, policymakers, patient advocacy organizations, and health care providers to support thoughtful implementation that protects continuity of care and access to treatment.

05/29/2026

Did you know the summer time between legislative sessions is one of the best opportunities to connect with elected officials and their staff?

Building strong relationships with your lawmakers is one of the most powerful ways to advance rare disease policy and help make sure our community’s voice is heard.

Join us on Wednesday, June 17 at 1 p.m. ET for a webinar on "Effective Lawmaker Engagement for Rare Disease Advocates." We’ll cover how to build and strengthen lasting relationships with your state lawmakers and connect with members of Congress while they are back home in your district.

Don’t miss this opportunity to learn practical advocacy strategies and feel more prepared to connect with legislators! RSVP today: https://bit.ly/431zfRL

Address

Bourbonnais, IL
60914

Website

Alerts

Be the first to know and let us send you an email when Hunter's Quest for the Cure posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Organization

Send a message to Hunter's Quest for the Cure:

Share